Background. Herd protection by meningococcal vaccines is conferred by population-level reduction of meningococcal nasopharyngeal colonization. Given the inverse epidemiological association between colonization by commensal Neisseria lactamica and meningococcal disease, we investigated whether controlled infection of human volunteers with N. lactamica prevents colonization by Neisseria meningitidis.
Asymptomatic oropharyngeal carriage of Neisseria meningitidis is prerequisite for meningococcal disease. In high-income countries, the highest carriage rates occur in young adults, particularly in educational facilities [1, 2] . Glycoconjugate vaccines have had dramatic effects on disease incidence, at least partly due to herd protection conferred by reduced carriage and transmission [3] , akin to the effect of pneumococcal and Haemophilus influenzae type B vaccines [4] . Recent vaccine developments include a new subcapsular vaccine, 4CMenB, which induces bactericidal antibodies against a range of strains, including serogroup B [5] , but the effect on carriage of serogroup B N. meningitidis is relatively modest [6] .
There is an epidemiological relationship between carriage of the commensal Neisseria lactamica and meningococcal disease. Age-specific rates of N. meningitidis carriage and disease were inversely proportional to carriage of N. lactamica [7] [8] [9] . Modeling has suggested a mean 4.7-year delay in meningococcal carriage following carriage of N. lactamica [10] . The mechanism of this relationship is undetermined, but is not due to crossprotective antibody production, as the early years of life associated with high rates of N. lactamica carriage predate the development of natural bactericidal meningococcal antibodies [11] . Furthermore, in a controlled infection study, intranasal inoculation of young adults with live N. lactamica was followed by development of humoral immunity to N. lactamica in those who carried the inoculated strain, but this did not induce significant cross-reactive antibodies [12] . In the current study, we sought direct evidence for a carriage prevention effect by conducting controlled infection with N. lactamica in healthy university students, the group that has the highest rates of acquisition of meningococci.
METHODS

Participants and Study Design
In a prospective, operator-blind challenge study, healthy participants aged 18-25 years were recruited from 2 universities in Sheffield, United Kingdom, between October and December 2011. A sample of 300 was determined a priori using data from a previous study [12] ( power: 80%; significance level: 5%; effect size: 50% reduction in challenge group vs a control group with 30% carriage). Participants were excluded if they were immunocompromised, were taking immune-modifying medications, had close contact with immunocompromised individuals, had current infection, were currently taking antibiotics, were smokers, or were pregnant. Participants from University A were randomized by sealed envelope to receive N. lactamica inoculation. University B participants would then receive a control solution. This design was employed to limit potential transmission of N. lactamica from test to control participants. By the fourth week of enrollment, a slow rate of enrollment from university A was observed, and an amendment to the protocol (approved by the institutional review board) was made to allow recruitment from both universities into the slow-recruiting group. Consequently, the control group was recruited entirely from individuals affiliated with university B, and the challenge group consisted of approximately 50% each from university A and B (Figure 1 ).
Neisseria lactamica Inocula
One hundred forty-nine participants received intranasal drops containing 10 4 colony-forming units (CFU) 
Symptom Reporting
All participants were asked to report upper respiratory tract and other symptoms, as well as adverse events, at each visit using a standard questionnaire.
Whole-Genome Sequencing
Neisseria meningitidis isolates from the control group from baseline and 2 and 26 weeks postchallenge, and all N. meningitidis samples from the N. lactamica challenge group, underwent whole-genome sequencing. Extraction was done using the Wizard Genomic DNA purification Kit (Promega) according to the manufacturer's protocols for bacteria. Genome sequencing was performed by the Oxford Genomics Centre based at the Wellcome Trust Centre for Human Genetics, University of Oxford, United Kingdom. Samples were quantified using PicoGreen (Invitrogen) and integrity was assessed using 1% E-Gel EX (Invitrogen). DNA was fragmented using an Episonic system. Distribution of fragments was determined using a Tapestation D1200 system (Agilent/Lab901 , and purified with AMPure XP beads. Size distribution was determined using a Tapestation 1DK system (Agilent/ Lab901), and multiplex pool concentrations were determined by PicoGreen. Pooled libraries were quantified using the quantitative PCR Library Quantification Kit and MX3005PTM instrument (Agilent). Sequencing was performed using the HiSeq 2000 to generate 100-bp paired end reads. Assembly was performed by the University of Oxford Department of Zoology. The resultant assemblies were uploaded to the Neisseria PubMLST database (http://pubmlst.org/neisseria/) and characterized using conventional MLST loci [14] . 
Reinoculation Phase
At week 26, all participants from both groups received a further inoculation of nasal drops containing 10 4 CFU of N. lactamica.
After 2 weeks, a final oropharyngeal swab was taken.
Statistical Analysis
Carriage of N. meningitidis and N. lactamica in each group at each time point was estimated with 95% binomial exact CIs. Differences between groups at each time point were assessed using Fisher exact test and between time points within groups by McNemar test. In multivariable logistic regression analysis, variables initially included were baseline covariates showing significant differences between the 2 groups or correlating with carriage of N. meningitidis at baseline. Variables were retained in a final model if they changed the odds ratio for the treatment effect by >20%. Stata software was employed for analyses. Point prevalence carriage rates were further analyzed for an effect on displacement of resident carriage and prevention of acquisition using Kaplan-Meier survival estimates and by the log-rank test. Displacement of carriage was defined as failure to detect carriage of N. meningitidis on 2 consecutive visits, after carrying N. meningitidis at baseline. Acquisition was defined as detection of N. meningitidis in those who were not carrying at baseline.
Study Approval and Registration
The study was approved by the National Health Service Research Ethics Committee (11/YH/0224), was overseen by an independent safety committee, and was conducted in accordance with the Declaration of Helsinki. Written informed consent was gained from participants prior to inclusion in the study. The study was registered with ClinicalTrials.gov (NCT02249598).
RESULTS
Study Population
A total of 310 participants were recruited, of whom 149 received nasal challenge with 10 4 CFU of N. lactamica, and 161 received sham control (Figure 1 ). The 2 groups shared similar baseline characteristics apart from small but significant differences in the female-to-male ratio, household densities, and month of first swab ( 
Carriage of N. lactamica in Challenged Participants
Carriage of N. lactamica prior to inoculation occurred in 6 of 310 participants in both groups (1.9% [95% CI, .4%-3.5%]) (Figure 2A ). Two weeks after inoculation, oropharyngeal (Figure 2A ). Two weeks after inoculation, 35 of 153 (24.4%) of the challenged participants and 38 of 157 (24.2%) of controls (P = .52) reported some upper respiratory tract symptoms (including nasal stuffiness/runny nose) since inoculation. No significant differences in symptom rates were observed over the course of the study. Four participants experienced serious adverse events but none were related to the study.
Effect of N. lactamica Administration on N. meningitidis Carriage
Neisseria meningitidis carriage in the control group increased over the course of the study to a peak of 33.6% at week 26 (48/143 [95% CI, 25.9%-41.9%]) ( Figure 2B ). Two weeks after inoculation, point prevalence of carriage of N. meningitidis in the challenge group had fallen from 24.2% (36/149) to 14.7% (21/143) (−9.5%; P = .006, McNemar test; Figure 2B) Figure 2D and are pictorially represented in Figure 2E , to provide an overview of the distribution of carriage. In multivariate analysis in which all variables except calendar month of first swab and smoking by housemates were removed from the analysis, as they did not change the odds ratio at any time point by more than 20% (Table 2 ), the effect of N. lactamica on N. meningitidis carriage remained significant.
Displacement of N. meningitidis by N. lactamica
Among those individuals who were carrying N. meningitidis at baseline, there was a greater reduction in detection of N. meningitidis at 2 weeks in the challenge group compared to controls ( Figure 3A ). This effect was most pronounced in individuals who were challenged and colonized by N. lactamica compared with the control group (5/11 [45.5%] of those who carried N. lactamica lost carriage of N. meningitidis vs 5/36 [13.9%] of those who did not carry N. lactamica; P = .039). There was a greater loss of resident carriage of N. meningitidis among carriers of N. lactamica throughout the study (Kaplan-Meier estimate, P = .013, log-rank test). Those who were challenged but not colonized by N. lactamica exhibited no significant increased loss of N. meningitidis events at any point during the study.
Effect of N. lactamica on Acquisition of N. meningitidis
In those participants who, at baseline, were not carrying N. meningitidis, we measured the acquisition of N. meningitidis carriage at subsequent visits over the 26-week course of the study. In the group who were challenged with, and colonized by N. lactamica, there was reduced acquisition of N. meningitidis over 26 weeks (P = .011) ( Figure 3B ), particularly over the first 16 weeks, when acquisition was almost completely inhibited. In this group, 13.3% (6/45) had acquired N. meningitidis by week 26, compared with 28% (14/50) of those who were challenged with but not colonized by N. lactamica and 29.2% (31/ 106) of the control group.
Carriage of N. lactamica Does Not Induce Resistance to Reinoculation of N. lactamica
At week 26, both groups were inoculated for a second time with 10 4 CFU of N. lactamica. Two weeks after the second inoculation, 36 of 142 (25.4% [95% CI, 18.4%-33.3%]) individuals from the control group were colonized with N. lactamica, compared with 44 of 117 (37.6% [95% CI, 28.8%-47%]) in the original challenge group. We identified 21 participants who had previously been challenged and colonized with N. lactamica, but who had cleared carriage (ie, had 2 consecutive negative swabs) prior to the rechallenge. In this group, 7 individuals (33.3%) had cultivable colonization detected at week 28, 2 weeks after inoculation. Of the people who had originally been challenged with N. lactamica, but in whom no colonization had been detected at any point in the study, 17 of 68 (25.0%) were colonized at week 28. There was no significant difference in induced carriage rates in those people who had been previously colonized with (but lost) N. lactamica and either the control group or the group challenged but not colonized.
Effect of Resident N. meningitidis Carriage on the Likelihood of N. lactamica Carriage After Nasal Challenge
Of the 36 individuals in the challenge group who were carrying N. meningitidis at baseline (week 0), 33 completed visits through week 26; among this group, 7 (21%) became colonized by N. lactamica before week 26, compared with 37% (41/110) of those who were not colonized with N. meningitidis at baseline (P = .10). At week 26 (when underlying N. meningitidis carriage rates were higher) following rechallenge of both the control and challenge group with N. lactamica, 13% (10/75) of those carrying N. meningitidis acquired N. lactamica after rechallenge vs 38% (70/184) of those who did not carry N. meningitidis (P < .001). This was not influenced by whether they had previously been challenged with N. lactamica at week 2. It is concluded that existing N. meningitidis carriage inhibits colonization by inoculated N. lactamica. CC53, CC213, and CC60), and these clonal complexes represented 41 (57.7%) of the samples at baseline, prior to challenge. Clonal complex distribution at baseline between the 2 groups was similar. Loss of carriage by week 2 among those challenged by N. lactamica who were carriers of N. meningitidis at baseline was not limited to specific clonal complexes (P = .59, Fisher exact test; Figure 4 ).
Carriage of N. lactamica Does Not Preferentially Inhibit
DISCUSSION
Herd protection by carriage reduction is a major effector of current meningococcal vaccines [15] . The current study reveals a potent effect of inoculated live N. lactamica on carriage and acquisition of the pathogen N. meningitidis. The size of the effect was superior to carriage reduction of the quadrivalent ACWY glycoconjugate vaccine that was observed in a recent study [6] in which no change in serogroup Y carriage occurred 4 weeks after receipt of vaccine, although an overall reduction of 39% was seen over the subsequent year. In contrast, the significant effect on "general" meningococcal carriage observed in the current study was apparent by 2 weeks and was sustained over months, and was restricted to those volunteers who exhibited carriage of N. lactamica after inoculation. The mechanism is either microbial competition within the nasopharynx, or innate immune responses that operate only in individuals actively carrying the commensal. As N. lactamica carriage rates waned, rates of N. meningitidis carriage in the challenge group increased. Therefore, an acquired immune response as a cause of the effect seems unlikely, as it would be expected to persist beyond the period of N. lactamica colonization. The effect we observed was broad spectrum and not apparently limited to specific sequence types of N. meningitidis. The reduction in N. meningitidis carriage was a combined result of displacement of resident N. meningitidis and prevention of acquisition. Innate immune responses could be responsible for this. Neisseria meningitidis may rely on a suppressed innate response to maintain colonization, whereas N. lactamica is able to colonize despite inducing a proinflammatory response [16] , which might explain why co-colonization of N. lactamica and N. meningitidis is so rare [17, 18] . Alternatively, CD5 + B1 cells [19] or a host-released soluble factor elicited by N. lactamica [20] may be responsible. Carriage rates and profiles for N. meningitidis in this study in the control and challenge group at baseline were comparable to other studies of students during the academic term [21] [22] [23] , as was the effect of smoking [24] .
Neisseria lactamica may therefore be a potential "bacterial medicine" to suppress meningococcal outbreaks. In other disease states involving the nasopharynx, such as otitis media, sinusitis, and bronchitis, similar potential roles for α-hemolytic streptococci and lactobacilli [25] [26] [27] have been suggested or demonstrated.
Regarding limitations, the design of this study involved 2 separate cohorts recruited from 2 different universities in the city of Sheffield. Each university was allocated either to the control or challenge arm to minimize confounding cross-transmission of N. lactamica. Due to slow recruitment of students from one of the universities, an amendment allowed recruitment from both institutions into the challenge arm. Other than 2 individuals colonized at baseline, only 1 person in the control group acquired N. lactamica during the study, suggesting that the amendment did not affect the results. One consequence of our design was a difference in the sex ratios and the sizes of households between the 2 groups; however, at baseline, rates of N. meningitidis carriage in both groups were equivalent. In multivariate analysis, which included sex and household size in the model, the effect of N. lactamica on N. meningitidis was preserved. Critically, crossover inoculation of controls with N. lactamica replicated the result.
Notes
